CROPS NEWS
Wed Jan 30, 2013 10:46 AM CST

(Dow Jones) -- Monsanto Co. has bought assets from a California-based company that uses microbes to improve crop production.

Monsanto also said that it made an equity investment in Synthetic Genomics Inc. and that the two companies reached a multiyear agricultural research agreement

The purchase of assets from Agradis, which Synthetic Genomics co-founded in 2011, includes the collection of microbes as well as the company's name. Terms of the deal weren't disclosed.

The assets build upon Monsanto's agricultural biological platform, called BioDirect, launched last year. Agricultural biologicals generally refer to seed or crop treatments derived from natural materials.

Agradis has ...

Quick View
  • Crop Tech Corner In this week's Crop Tech Corner, a new, faster method of testing soybean cyst nematode samples is...
  • Profit Makeover When Curtis Schallert's 40-year-old stands of Kentucky-31 fescue petered out a few years ago, the...
  • UAVs Taking Flight in Ag The FAA this month began accelerating its exemption approvals for companies testing the skies wit...
  • Iowa's Field of Dreams Current Iowa land values are running about 16% below peak 2013 levels. That's according to a real...
  • Drought Recovery March auctions show cash rent shocks could mount in 2016.
  • Competing for Dollars Beef is far from a loser in the daily race for buyers at meat counters across the country. It's n...
  • CDC: No Human H5N2 Cases So Far So far, there are no reported cases of H5N2 in humans, but transmission of the highly contagious ...
  • Ask the Vet Can I cure my cow's uterine infection with an infusion?
Related News Stories
Food Industry Seeks GMO Label Law Block
Production Blog
EU OKs High-Oleic Traits
EU Advances Biotech Opt-Out
Crop Tech Corner
EU Could Alter Biotech Trade
Bean Oil Health Questioned
Glyphosate Controversy
APHIS Works on Biotech Regs
Production Blog